Skip to main content

Pancreatic Ductal Carcinoma clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

    Sorry, in progress, not accepting new patients

    Study CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab (MGD019). The study is designed to characterize safety, tolerability, pharmacokinetics (PK), immunogenicity, pharmacodynamics, and preliminary…

    San Francisco, California and other locations

Last updated: